TRIO 017

• Research type

  Research Study

• Full title

  A phase II, open label multicenter trial of panobinostat (LBH589) monotherapy in women with HER2 negative locally recurrent or metastatic breast cancer

• IRAS ID

  12990

• Sponsor organisation

  Cancer International Research Group

• Eudract number

  2008-003176-21

• Clinicaltrials.gov Identifier

  NCT00777049

• Research summary

  The aim of this study is to assess the benefit of oral panobinostat monotherapy given to women with HER2-negative locally recurrent or metastatic breast cancer.

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  09/H0408/60

• Date of REC Opinion

  5 Jun 2009

• REC opinion

  Further Information Favourable Opinion